誤解を招くハーブアーユルヴェーダのブランド名

Assessment of prescribing pattern of drugs and completeness of prescriptions as per the World Health Organization prescribing indicators in various Indian tertiary care centers: A multicentric study by Rational Use of Medicines Centers-Indian Council of Medical Research network under National Virtual Centre Clinical Pharmacology activity.

Indian journal of pharmacology·2022

Treatment outcome of extrapulmonary tuberculosis under Revised National Tuberculosis Control Programme.

The Indian journal of tuberculosis·2017

Dual hit lipopolysaccharide & oleic acid combination induced rat model of acute lung injury/acute respiratory distress syndrome.

The Indian journal of medical research·2016

Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax.

Malaria research and treatment·2014

A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India.

Indian journal of cancer·2012

HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.

The International journal of risk & safety in medicine·2011

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Traditionalism mediates social learning: Biases in acceptance of novel health interventions among Himba pastoralists.

Evolution, medicine, and public health·2026

[Retracted] Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1.

Experimental and therapeutic medicine·2026

Associating Multimorbidity Patterns With Healthcare Utilization and Unmet Healthcare Needs Among Older Koreans Living Alone.

Geriatrics & gerontology international·2026

From Ethnobotany to Pharmacognosy: A Review of <i>Firmiana colorata</i>.

Plants (Basel, Switzerland)·2026

Healthcare experiences of refugees and asylum-seekers resettled in non-metropolitan high-income settings: a systematic review and thematic synthesis of qualitative evidence.

International journal for equity in health·2026

Mislabeling and Status of Semisynthetic Kratom-Derived Products in the US Market.

Drug testing and analysis·2026

関連する実験動画

誤解を招くハーブアーユルヴェーダのブランド名

関連する概念動画

Treatment outcome of extrapulmonary tuberculosis under Revised National Tuberculosis Control Programme.

Dual hit lipopolysaccharide & oleic acid combination induced rat model of acute lung injury/acute respiratory distress syndrome.

Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax.

A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India.

HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Traditionalism mediates social learning: Biases in acceptance of novel health interventions among Himba pastoralists.

[Retracted] Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1.

Associating Multimorbidity Patterns With Healthcare Utilization and Unmet Healthcare Needs Among Older Koreans Living Alone.

From Ethnobotany to Pharmacognosy: A Review of <i>Firmiana colorata</i>.

Healthcare experiences of refugees and asylum-seekers resettled in non-metropolitan high-income settings: a systematic review and thematic synthesis of qualitative evidence.

Mislabeling and Status of Semisynthetic Kratom-Derived Products in the US Market.

関連する実験動画

誤解を招くハーブアーユルヴェーダのブランド名

関連する概念動画

関連記事